Pittsford Performance Care · Neurologic Outcomes Registry

Neurologic Outcomes Registry

Aggregated outcomes from patients treated for concussion, vestibular dysfunction, and autonomic dysregulation.

"Directed treatment. Measured recovery. Durable results."

CDRR
Constraint-Directed Recovery Rate
1
Completed
of 109 total
Registry episodes
Durability
Maintained at follow-up

Constraint-Directed Recovery Rate (CDRR): Completed episodes achieving clinically meaningful symptom improvement, functional recovery, and durable stability at follow-up.

Registry data last updated: March 14, 2026 — continuously updated as episodes are completed.

Registry Aim

The Pittsford Performance Care Neurologic Outcomes Registry evaluates whether treatment delivered through the Care Track Model — directed at the identified Primary Constraint — produces clinically meaningful and durable improvement in symptom burden and functional capacity.

Each episode of care identifies the neurologic system acting as the Primary Constraint preventing adaptation. Treatment is directed at that system and outcomes are measured using validated clinical instruments.

Pittsford Performance Care · Pittsford & Rochester, NY

What the Neurologic Outcomes Registry Measures

The Pittsford Performance Care Neurologic Outcomes Registry is a prospective clinical registry that tracks outcomes across three neurologic domains: post-concussion syndrome, vestibular dysfunction, and autonomic dysregulation. For each completed episode of care, the registry records symptom burden at intake and discharge, functional recovery status, and durability of improvement at follow-up.

Symptom Burden
Validated questionnaire scores at intake and discharge, measuring the magnitude of symptom reduction.
Functional Recovery
Return-to-work, return-to-learn, and return-to-sport status at episode completion.
Durability of Improvement
Whether symptom improvement is maintained at structured follow-up after discharge.
Neurologic Constraint Classification
The primary neurologic system identified as the constraint limiting recovery, recorded for each episode.

Registry Population

Cohort characteristics for interpreting outcomes. All data are aggregated and de-identified.

87
Total Episodes
1
Completed
86
Active
0
Follow-Ups Done
Follow-Up Rate

All data are aggregated and de-identified.

Care Track Model

The registry logic — from domain identification to durable outcome.

Registry Domain
Concussion · Vestibular · Autonomic
Primary Constraint Identification
Neurologic system acting as the primary barrier
Care Track Treatment
Directed at the identified constraint system
Symptom Improvement
Validated instrument score reduction
Functional Recovery
Return to work · school · sport
Durable Outcome
Maintained at 90-day follow-up
What is a Primary Constraint?

The Primary Constraint is the neurologic system identified as the primary barrier preventing a patient from adapting and recovering. Treatment directed at this system — rather than at symptoms alone — is the core principle of the Care Track Model.

VestibularOculomotorCervicogenicBrainstemCerebellarAutonomicFrontal/CognitiveLimbic/Affective
CDRR — Three Criteria
Criterion 1
Clinically meaningful symptom improvement (CMC achieved)
Criterion 2
Functional recovery (structured return-to-function marker)
Criterion 3
Durability (follow-up score ≤ discharge score at 90 days)
The Care Track Model
The clinical framework used to structure each episode of care in the registry.

The Care Track Model is a structured clinical framework that organizes neurologic rehabilitation into four sequential phases. Each episode of care in the registry follows this framework, which ensures that treatment is directed at the specific neurologic system limiting recovery rather than addressing symptoms in isolation.

  1. 1
    Identify the Primary Constraint
    Evaluate the neurologic system — vestibular, oculomotor, cervicogenic, autonomic, brainstem, or cerebellar — acting as the primary barrier to recovery.
  2. 2
    Deliver Targeted Treatment
    Direct therapeutic interventions specifically at the identified Primary Constraint system, not at symptom clusters alone.
  3. 3
    Measure Outcomes with Validated Instruments
    Track symptom burden and functional status using standardized questionnaires at intake and discharge.
  4. 4
    Confirm Durability of Recovery
    Conduct structured follow-up to verify that improvement is maintained after discharge.
How Outcomes Are Measured
Validated clinical instruments used across all registry episodes.

The registry uses four validated clinical instruments to measure outcomes. Each instrument is administered at intake and at discharge, enabling a standardized pre-to-post comparison within each episode of care.

RPQRivermead Post-Concussion Questionnaire
A 16-item validated scale measuring the frequency and severity of post-concussion symptoms including headache, dizziness, memory difficulty, and fatigue. Used for post-concussion domain episodes.
DHIDizziness Handicap Inventory
A 25-item self-report measure evaluating the functional, emotional, and physical impact of dizziness and balance disorders. Used for vestibular domain episodes.
COMPASS-31Composite Autonomic Symptom Score
A 31-item questionnaire assessing autonomic symptom burden across six domains including orthostatic intolerance, secretomotor function, and vasomotor symptoms. Used for autonomic domain episodes.
SF-36Short Form Health Survey
An 8-domain measure of functional health status covering physical functioning, role limitations, bodily pain, general health, vitality, social functioning, emotional role, and mental health. Used across all domains.

Primary Constraint Distribution

Primary Constraint reflects the neurologic system identified as the primary barrier preventing adaptation.

Vestibular
108(99.1%)
Oculomotor
1(0.9%)

Denominator: 109 classified episodes. Legacy episodes without constraint classification are excluded.

Symptom Burden Outcomes

Distinguishing "any improvement" from "clinically meaningful change" (CMC) by domain.

RPQ

Post-Concussion

1 completed episode

45.0
Avg Intake
6.0
Avg Discharge
Any Improvement100%
Clinically Meaningful100%
Avg CMC magnitude: 3/3

Functional Recovery

Functional recovery reflects a patient's ability to return to normal daily activities.

Post-Concussion
1 episode with milestone data
Return to Sport100%

Durability at Follow-Up

Whether improvements persist after discharge — the third criterion of the CDRR.

Follow-Up Completion
90-day follow-up response rates by domain.

Durability metrics require completed follow-up data.

Maintained Improvement
Follow-up score ≤ discharge score (lower-is-better instruments).
Post-Concussion
Constraint-Directed Recovery Rate (CDRR)
Insufficient data for CDRR calculation. Requires CMC data, functional markers, and completed follow-up.

Treatment Exposure

These metrics provide context for care delivery — visit count and resolution time.

4
Avg Visits
to discharge
4
Median Visits
to discharge
Avg Resolution
intake to discharge
Median Resolution
intake to discharge

Based on 1 episode with complete visit count and resolution data. Episodes with zero or missing values are excluded.

Registry Methodology

Outcome Instruments
Validated clinical instruments used to measure symptom burden.
RPQ
Rivermead Post-Concussion Symptoms Questionnaire
Post-Concussion
DHI
Dizziness Handicap Inventory
Vestibular / Balance
COMPASS-31
Composite Autonomic Symptom Score
Autonomic Dysfunction
SF-36
Short Form Health Survey
General Function
Measurement Structure
Standardized episode structure for outcome measurement.
1
Intake
Baseline validated instrument score recorded at initial evaluation.
2
Discharge
Discharge score recorded at episode completion. CMC calculated against baseline.
3
Follow-Up
90-day follow-up score recorded. Durability assessed against discharge score.

"The registry measures real clinical outcomes using validated instruments and standardized episode structure."

Frequently Asked Questions

What is the Neurologic Outcomes Registry?

The Pittsford Performance Care Neurologic Outcomes Registry is a prospective clinical registry that tracks outcomes for patients treated for post-concussion syndrome, vestibular dysfunction, and autonomic dysregulation. It records symptom burden, functional recovery, and durability of improvement using validated clinical instruments.

What is the Care Track Model?

The Care Track Model is a structured clinical framework that identifies the neurologic system acting as the Primary Constraint limiting recovery, directs treatment at that system, measures outcomes with validated instruments, and confirms durability of improvement at follow-up. The registry is designed to test whether this constraint-directed approach produces better outcomes.

How are concussion outcomes measured?

Post-concussion outcomes are measured using the Rivermead Post-Concussion Questionnaire (RPQ), a validated 16-item scale administered at intake and discharge. Functional recovery status and durability at follow-up are also recorded. The SF-36 is used across all domains to measure functional health status.

What does clinically meaningful change mean?

Clinically meaningful change refers to a reduction in validated symptom scores that exceeds the established minimal clinically important difference (MCID) for each instrument. For the RPQ, this is a defined threshold of symptom score reduction. Achieving clinically meaningful change means the improvement is large enough to be noticeable and significant to the patient, not just statistically detectable.

What is the Constraint-Directed Recovery Rate?

The Constraint-Directed Recovery Rate (CDRR) is the registry’s primary outcome metric. It is the proportion of completed episodes in which the patient achieved clinically meaningful symptom improvement, functional recovery marker, and durable stability at follow-up. It is the registry’s answer to the question: does treatment directed at the identified Primary Constraint produce durable, meaningful recovery?

Why Constraint Identification Matters

Recovery from neurologic conditions such as concussion, vestibular dysfunction, and autonomic dysregulation does not follow a uniform trajectory. In many cases, the limiting factor is not the severity of the initial injury but rather the specific neurologic system that is failing to adapt. The Care Track Model refers to this as the Primary Constraint.

When the Primary Constraint is correctly identified — whether vestibular, oculomotor, cervicogenic, autonomic, brainstem, or cerebellar — treatment can be directed precisely at that system. The registry exists to test whether this constraint-directed approach produces better outcomes than symptom-based treatment alone. Each episode recorded in the registry contributes to that question.

The Constraint-Directed Recovery Rate (CDRR) is the registry’s primary outcome metric: the proportion of completed episodes in which the patient achieved clinically meaningful symptom improvement, functional recovery, and durable stability at follow-up.

Clinical Note

Outcomes reported here represent aggregated registry data. Individual results vary depending on neurologic presentation, duration of symptoms before treatment, and other clinical factors. All data are de-identified. This registry is maintained for quality improvement and research purposes and does not constitute a clinical trial or systematic review.

For the full outcome registry including musculoskeletal cases, visit the PPC Outcome Registry.